Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Lanier

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptorJoseph Pontillo, Joseph A Tran, Beth A Fleck, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated miceJoseph Pontillo, Joseph A Tran, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptorJoseph Pontillo, Joseph A Tran, Melissa Arellano, et al.
Journal of Medicinal Chemistry|May 23, 2014
A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT)Marion Lanier, Geza Ambrus, Derek C Cole, et al.
Cell Reports|November 24, 2024
High-affinity agonists reveal recognition motifs for the MRGPRD GPCRChunyu Wang, Yongfeng Liu, Marion Lanier, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure"Marion Lanier, Jason Pickens, Simone V Bigi, et al.
Journal of Medicinal Chemistry|August 5, 2005
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZhiqiang Guo, John E Tellew, Raymond S Gross, et al.
The Journal of Allergy and Clinical Immunology|July 6, 2024
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonistsJoshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptorJoseph Pontillo, Joseph A Tran, Beth A Fleck, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated miceJoseph Pontillo, Joseph A Tran, Stacy Markison, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptorJoseph Pontillo, Joseph A Tran, Melissa Arellano, et al.
Journal of Medicinal Chemistry|May 23, 2014
A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT)Marion Lanier, Geza Ambrus, Derek C Cole, et al.
Cell Reports|November 24, 2024
High-affinity agonists reveal recognition motifs for the MRGPRD GPCRChunyu Wang, Yongfeng Liu, Marion Lanier, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart FailureMarion Lanier, Jason Pickens, Simone V Bigi, et al.
ACS Medicinal Chemistry Letters|December 21, 2017
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure"Marion Lanier, Jason Pickens, Simone V Bigi, et al.
Journal of Medicinal Chemistry|August 5, 2005
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZhiqiang Guo, John E Tellew, Raymond S Gross, et al.
The Journal of Allergy and Clinical Immunology|July 6, 2024
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonistsJoshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Pageof 2